GSC
HOOK

Ground Swell Capital’s HOOKIPA Pharma HOOK Stock Holding History

Ground Swell Capital’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,247
Closed -$7.38K – 206
2024
Q2 		$7.38K Buy
+1,247
New +$9.89K 0.01% 155

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Ground Swell Capital's HOOK Position: Q3 2024 in Review

Ground Swell Capital sold out of HOOKIPA Pharma (HOOK) in Q3 2024, closing a stake of 1,247 shares — an estimated $7.38K sold.

Ground Swell Capital first reported a position in HOOK in Q2 2024 and held it in 1 quarter. The position peaked at $7.38K in Q2 2024. 35 funds tracked by Wall St. Rank hold HOOK as of Q3 2024.

  • Ground Swell Capital reported no remaining HOOKIPA Pharma position as of Q3 2024 after selling out during the quarter.
  • Ground Swell Capital sold 1,247 HOOKIPA Pharma shares in Q3 2024, an estimated $7.38K.
  • Ground Swell Capital first reported a position in HOOKIPA Pharma in Q2 2024 and held it in 1 quarter.
  • Ground Swell Capital's HOOKIPA Pharma position peaked at $7.38K in Q2 2024.
  • 35 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2024.

Based on Ground Swell Capital's 13F filing for Q3 2024, filed 29 Oct 2024.